BIT
ABBV icon

BlackRock Institutional Trust’s AbbVie ABBV Stock Holding History

BlackRock Institutional Trust’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-2,100
Closed -$132K – 3824
2016
Q3 		$132K Buy
+2,100
New +$136K ﹤0.01% 3668

Other funds holding ABBV

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
State Farm Mutual Automobile Insurance
State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
BG
BlackRock Group London, United Kingdom $210B AUM 15.5% 1-Year Est. Return

BlackRock Institutional Trust's ABBV Position: Q4 2016 in Review

BlackRock Institutional Trust increased its AbbVie (ABBV) stake by 1.4% in Q4 2016, buying an estimated $36.4M and bringing the position to 43,460,085 shares worth $2.72B. The position accounts for 0.4% of the portfolio, ranked #39.

BlackRock Institutional Trust first reported a position in ABBV in Q2 2013 and has held it in 15 quarters since. The position peaked at $3.08B in Q2 2015. 1,691 funds tracked by Wall St. Rank hold ABBV as of Q4 2016.

  • BlackRock Institutional Trust held 43,460,085 shares of AbbVie worth $2.72B as of Q4 2016.
  • BlackRock Institutional Trust bought 596,256 AbbVie shares in Q4 2016, an estimated $36.4M.
  • AbbVie made up 0.4% of BlackRock Institutional Trust's portfolio in Q4 2016, its #39 holding.
  • BlackRock Institutional Trust first reported a position in AbbVie in Q2 2013 and has held it in 15 quarters since.
  • BlackRock Institutional Trust's AbbVie position peaked at $3.08B in Q2 2015.
  • 1,691 funds tracked by Wall St. Rank held AbbVie as of Q4 2016.

Based on BlackRock Institutional Trust's 13F filing for Q4 2016, filed 10 Feb 2017.